15 May 2018
MTPConnect welcomes the national launch of the Industry Mentoring Network in STEM (IMNIS) program, in conjunction with Industry Growth Centres NERA and METSIgnited. IMNIS has evolved from a small pilot program into a prestigious mentoring initiative involving more than 400 people.
11 May 2018
Three outstanding female leaders have been presented with the 2018 BioMelbourne Network Women in Leadership Awards, celebrating and recognising women at the different stage of their careers who have made outstanding contributions to advancing the biotechnology, medical technology and pharmaceutical sector.
10 May 2018
Find out more about specific initiatives announced in Budget 2018, with a targeted focus on economic growth to drive ongoing innovation, research translation, industry-research collaboration and commercialisation in the Australian MTP sector.
09 May 2018
MTPConnect has welcomed the Australian Government’s 2018 Budget, with a targeted focus on economic growth to drive ongoing innovation, research translation, industry-research collaboration and commercialisation in the Australian MTP sector.
07 May 2018
MTPConnect is delighted to announce that it has appointed Dr Dan Grant as Chief Executive Officer. Dr Grant will commence the role in July 2018, bringing a wealth of experience to MTPConnect and the Australian MTP sector, from an extensive career in the pharmaceutical, medical research and higher education sectors.
30 April 2018
A new professional development program on the commercialisation of medical technology opens applications today with the launch of QUT’s The BridgeTech Program, supported by MTPConnect.
26 April 2018
MTPConnect invites the Australian medical technology sector to join the Australian delegation to The MedTech Conference—September 23 – 26, 2018 in Philadelphia, Pennsylvania—to showcase outstanding innovative medical technologies, Australia's unique capabilities, and build invaluable inroads into international markets.
19 April 2018
Compounds Australia at Griffith University announced today that it has finalised the purchase of the state-of-the-art Hamilton Verso M3 automated compound storage system, part of the Hit ID Platform supported by the MTPConnect Project Fund Program.
17 April 2018
MTPConnect and the Minister for Health, the Hon Greg Hunt MP, today announced the first 11 recipients of $10 million investment from the Australian Government’s $35 million BioMedTech Horizons program. The program aims to help Australia move more cutting-edge ideas and breakthrough discoveries towards proof-of-concept and commercialisation.
16 April 2018
ANDHealth is now accepting applications for the ANDHealth+ (ANDHealth Plus) 2018 Program from mid-stage digital health companies looking to strengthen their clinical and commercial business case in advance of raising venture capital and/ or entering international markets.
13 April 2018
The new Digital Health CRC (Cooperative Research Centre) will invest over $200 million to develop and test digital health solutions that work for real patients in real hospitals and health services, while equipping Australians to better manage their own health and wellness.
12 April 2018
Utilising a 15-month focused industry-led curriculum, The Actuator Accelerator Program will take Seed ventures to Series A investment; leading into clinical trials, advanced manufacturing, and at-scale technology deployment.
11 April 2018
MTPConnect and BioPacific Partners are jointly launching an exciting new initiative to assist Australian medical technology and pharmaceutical companies to better prepare and position themselves to engage successfully with multinational companies.
28 March 2018
The Wound Management Innovation CRC has today announced incorporation and registration for one of its legacy vehicles, Wound Innovations, providing optimal patient care through the delivery of clinical services, telehealth, education, credentialing and ongoing research.
23 March 2018
AusBiotech’s Asian Investment Series – which has received funding via the MTPConnect Project Fund Program – assembled Australian life science companies together with Chinese investors to connect, seek investment opportunities and work on their pitching skills.